The approach streamlines traditional methods used to verify gene expression in modified plants and can better detect plant physiology related to disease or nutrient stress, accelerating the ...

The global biosensors market is set for substantial growth, with a projected increase in market value from US$ 32.14 billion in 2024 to US$ 75.84 billion by 2033, reflecting a compound annual growth ...

Biolinq has raised $100 million in venture capital financing to help complete the development of its wearable glucose ...

The study defines biosensors as analytical devices that convert biological reactions into measurable signals, such as changes ...

The Biophotonics Market, long associated with healthcare diagnostics and advanced imaging, is undergoing a transformative ...

LifeSignals introduces UbiqVue Holter System in partnership with UltraLinQ at Heart Rhythm 2025: Milpitas, California Wednesday, April 23, 2025, 12:00 Hrs [IST] LifeSignals, Inc., ...

For the design, development and bioanalytical application of an ultra-high frequency acoustic wave device for the antifouling-based detection of biological species in complex media such as serum.

Biolinq has completed its pivotal trial and submitted its wearable biosensor to the FDA for regulatory review.

Monash University scientists have developed a new (preclinical) method to distinguish between chronic pain subtypes, such as ...